Survival analysis of follow-up results from the 100 clinical cases showed that increased expression of HLA-DQA1 significantly prolonged survival in RCC, while increased expression of IL-34 significantly prolonged survival in LCC. The gene discussed is HLA-DQA1; the disease is leukoencephalopathy with calcifications and cysts.